share_log

中基長壽科學：自願公告生物製品貿易合同

ZHONG JI LS: VOLUNTARY ANNOUNCEMENTBIOLOGICAL PRODUCT TRADING CONTRACT

HKEX ·  Mar 28 19:54
Summary by Futu AI
中基長壽科學集團有限公司（「中基長壽」）於2024年3月28日宣布，其間接非全資附屬公司四川中基冠德生物科技有限公司的全資附屬公司中基冠德生物科技（香港）有限公司與甘肅阿爾康生物工程股份有限公司慶城縣分公司簽署了總值約人民幣5600萬元（相當於約6048萬港元）的生物製品貿易合同。該合同按照甘肅阿爾康的需求分批供應生物製品。中基長壽表示，此次合同的簽訂將有助於公司進一步拓展國內市場，並為其生物科技業務提供擴展機會，預期將為集團帶來穩定且持續增長的收入。甘肅阿爾康為一家集多元化生物科技業務於一身的高新科技企業，且與中基長壽及其關連人士獨立無關。董事會認為貿易合同的條款公平合理，並符合正常商業條款。
中基長壽科學集團有限公司（「中基長壽」）於2024年3月28日宣布，其間接非全資附屬公司四川中基冠德生物科技有限公司的全資附屬公司中基冠德生物科技（香港）有限公司與甘肅阿爾康生物工程股份有限公司慶城縣分公司簽署了總值約人民幣5600萬元（相當於約6048萬港元）的生物製品貿易合同。該合同按照甘肅阿爾康的需求分批供應生物製品。中基長壽表示，此次合同的簽訂將有助於公司進一步拓展國內市場，並為其生物科技業務提供擴展機會，預期將為集團帶來穩定且持續增長的收入。甘肅阿爾康為一家集多元化生物科技業務於一身的高新科技企業，且與中基長壽及其關連人士獨立無關。董事會認為貿易合同的條款公平合理，並符合正常商業條款。
China Key Longevity Science Group Limited (“China Key Longevity”) announced on 28 March 2024 the acquisition of its indirect non-wholly owned subsidiary Sichuan Zhongkiguande Biotechnology Co., Ltd. and Gansu Alkan Bioengineering Co., Ltd. and Gansu Alkan Bioengineering Co., Ltd. The county branch signed a trade contract for biological products with a total value of approximately RMB5600 million (equivalent to approximately HK$6048 million). The contract will supply biological products in batches according to the needs of Gansu Alkan. SME said that the signing of the contract will help the company further expand its domestic market and provide expansion opportunities for its biotechnology business, which is expected to bring stable and sustained revenue growth to the Group. Gansu Alkan is a high-tech enterprise that brings together a diverse biotech business and is independent of China's longevity and its affiliates. The Board considers that the terms of the trade contract are fair and reasonable and comply with normal commercial terms.
China Key Longevity Science Group Limited (“China Key Longevity”) announced on 28 March 2024 the acquisition of its indirect non-wholly owned subsidiary Sichuan Zhongkiguande Biotechnology Co., Ltd. and Gansu Alkan Bioengineering Co., Ltd. and Gansu Alkan Bioengineering Co., Ltd. The county branch signed a trade contract for biological products with a total value of approximately RMB5600 million (equivalent to approximately HK$6048 million). The contract will supply biological products in batches according to the needs of Gansu Alkan. SME said that the signing of the contract will help the company further expand its domestic market and provide expansion opportunities for its biotechnology business, which is expected to bring stable and sustained revenue growth to the Group. Gansu Alkan is a high-tech enterprise that brings together a diverse biotech business and is independent of China's longevity and its affiliates. The Board considers that the terms of the trade contract are fair and reasonable and comply with normal commercial terms.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.